Core Viewpoint - The company, First Pharmaceutical, is experiencing a decline in stock price and is actively engaging with investors regarding its business operations and partnerships in the healthcare sector [1][6]. Group 1: Stock Performance - As of April 11, 2025, First Pharmaceutical's stock closed at 11.96 yuan, down 1.73%, with a turnover rate of 2.19% and a trading volume of 48,700 shares, amounting to a total transaction value of 58.71 million yuan [1]. - On the same day, the net outflow of main funds was 4.67 million yuan, accounting for 7.96% of the total transaction value [6][7]. Group 2: Business Operations - The company has some stores that are designated as tax refund shops for outbound travelers in Shanghai [2]. - First Pharmaceutical is collaborating with partners to create a health weight management experience area at its flagship store, offering services such as health data tracking and personalized weight management [3]. - The company’s retail pharmacies can accept electronic prescriptions issued by internet medical institutions [4][5]. Group 3: Investor Engagement - The company is actively responding to investor inquiries regarding its business strategies and partnerships, indicating a focus on transparency and engagement with stakeholders [2][3][4][5].